首页 > 最新文献

Substance abuse最新文献

英文 中文
Safety and Efficacy of A Digital Therapeutic for Substance Use Disorder: Secondary Analysis of Data from A Nida Clinical Trials Network Study 物质使用障碍数字治疗的安全性和有效性:来自Nida临床试验网络研究数据的二次分析
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-04-14 DOI: 10.1080/08897077.2022.2060425
Y. Maricich, E. Nunes, A. Campbell, J. Botbyl, Hilary F Luderer
Background: Traditional treatments for substance use disorders (SUDs) rely heavily on face-to-face interactions, which pose substantial limitations for patients. A clinical trial of a digital therapeutic (DT), delivering behavioral therapy demonstrated safety and efficacy in a population including patients with opioid use disorder (OUD) not treated with buprenorphine, which is not a guideline-recommended approach. This study re-analyzed the data excluding patients with OUD to more closely approximate real-world patient populations. Methods: Secondary analysis of patients with substance use disorders related to alcohol, cannabis, cocaine, or other stimulants (n = 399, patients with OUD excluded) from a previously-published randomized controlled trial. Patients received 12-weeks of outpatient treatment-as-usual (TAU; n = 193) or TAU with reduced counseling plus a DT (n = 206) providing computerized cognitive behavioral therapy and contingency management. Primary outcomes were abstinence in weeks 9–12 and retention in treatment. Results: The 399 patients in this analysis (206 in the DT group and 193 in the TAU group) reported substance use disorders related to alcohol, cannabis, cocaine, or other stimulants (e.g., methamphetamines). Demographic and baseline characteristics including age, sex, race, education, and reported primary substance use disorder were balanced between treatment groups. Abstinence was significantly higher in the DT group compared to TAU (40.3 vs. 17.6%; p < 0.001) as was retention in therapy (76.2 vs. 63.2%, p = 0.004). Intergroup adverse event rates were not significantly different (p = 0.68). Conclusions: The results demonstrate that use of a DT safely increased abstinence (reduced substance use) and retention in treatment among patients with substance use disorders related to alcohol, cannabis, cocaine, or other stimulants (including methamphetamines).
背景:物质使用障碍(sud)的传统治疗严重依赖于面对面的互动,这对患者造成了很大的限制。一项数字治疗(DT)的临床试验表明,在包括阿片类药物使用障碍(OUD)患者在内的人群中,提供行为治疗的安全性和有效性,这些患者未接受丁丙诺啡治疗,丁丙诺啡不是指南推荐的方法。本研究重新分析了排除OUD患者的数据,以更接近现实世界的患者群体。方法:对先前发表的一项随机对照试验中与酒精、大麻、可卡因或其他兴奋剂相关的物质使用障碍患者(n = 399,排除OUD患者)进行二次分析。患者接受了12周的门诊常规治疗(TAU;n = 193)或TAU减少咨询加DT (n = 206)提供计算机认知行为治疗和应急管理。主要结果是第9-12周的戒断和治疗的持续。结果:该分析中的399例患者(DT组206例,TAU组193例)报告了与酒精、大麻、可卡因或其他兴奋剂(如甲基苯丙胺)相关的物质使用障碍。人口统计学和基线特征包括年龄、性别、种族、教育程度和报告的原发性物质使用障碍在治疗组之间是平衡的。DT组的戒断程度明显高于TAU组(40.3 vs 17.6%;P < 0.001),治疗中的滞留率(76.2比63.2%,P = 0.004)。组间不良事件发生率差异无统计学意义(p = 0.68)。结论:结果表明,在与酒精、大麻、可卡因或其他兴奋剂(包括甲基苯丙胺)相关的物质使用障碍患者中,安全地使用DT可以增加戒断(减少物质使用)和保持治疗。
{"title":"Safety and Efficacy of A Digital Therapeutic for Substance Use Disorder: Secondary Analysis of Data from A Nida Clinical Trials Network Study","authors":"Y. Maricich, E. Nunes, A. Campbell, J. Botbyl, Hilary F Luderer","doi":"10.1080/08897077.2022.2060425","DOIUrl":"https://doi.org/10.1080/08897077.2022.2060425","url":null,"abstract":"Background: Traditional treatments for substance use disorders (SUDs) rely heavily on face-to-face interactions, which pose substantial limitations for patients. A clinical trial of a digital therapeutic (DT), delivering behavioral therapy demonstrated safety and efficacy in a population including patients with opioid use disorder (OUD) not treated with buprenorphine, which is not a guideline-recommended approach. This study re-analyzed the data excluding patients with OUD to more closely approximate real-world patient populations. Methods: Secondary analysis of patients with substance use disorders related to alcohol, cannabis, cocaine, or other stimulants (n = 399, patients with OUD excluded) from a previously-published randomized controlled trial. Patients received 12-weeks of outpatient treatment-as-usual (TAU; n = 193) or TAU with reduced counseling plus a DT (n = 206) providing computerized cognitive behavioral therapy and contingency management. Primary outcomes were abstinence in weeks 9–12 and retention in treatment. Results: The 399 patients in this analysis (206 in the DT group and 193 in the TAU group) reported substance use disorders related to alcohol, cannabis, cocaine, or other stimulants (e.g., methamphetamines). Demographic and baseline characteristics including age, sex, race, education, and reported primary substance use disorder were balanced between treatment groups. Abstinence was significantly higher in the DT group compared to TAU (40.3 vs. 17.6%; p < 0.001) as was retention in therapy (76.2 vs. 63.2%, p = 0.004). Intergroup adverse event rates were not significantly different (p = 0.68). Conclusions: The results demonstrate that use of a DT safely increased abstinence (reduced substance use) and retention in treatment among patients with substance use disorders related to alcohol, cannabis, cocaine, or other stimulants (including methamphetamines).","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41820912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Factors Associated with Binge Drinking—Findings from 2019 Kansas Behavioral Risk Factor Surveillance System 与酗酒相关的因素——来自2019年堪萨斯州行为危险因素监测系统的研究结果
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-04-14 DOI: 10.1080/08897077.2022.2060437
S. Lines, Aliya Marroquin, Steve Corbett, Julie Sergeant, Won Choi, B. Faseru
Background: In the U.S., excessive drinking accounts for one in 10 deaths among adults aged 20–64 years old. Binge drinking is a common form of excessive alcohol consumption that contributes to this chilling statistic. Binge drinking is defined as women consuming four or more drinks or men consuming five or more drinks within a 2-h time span. Examining existing data on risk factors for binge drinking can inform strategies to prevent this deadly practice. Methods: The 2019 Kansas Behavioral Risk Factor Surveillance System (BRFSS) dataset consists of data collected from 11,368 non-institutionalized adults aged 18 years and older with landline or cell phones. The dependent variable in this study was binge drinking status. The independent variables included several sociodemographic variables and risk factors. Data were analyzed using descriptive statistics, bivariate analysis, single logistic regression, and multivariable logistic regression. Results: In the population, 1,447 (17.4%) were reported to be binge drinkers. Significant factors associated with binge drinking in the final model included sex (aOR = 0.53 (0.45–0.63)), age (18–24 years old aOR = 8.77 (6.02–12.79); 25–34 years old aOR = 7.10 (5.35–9.42); 35–44 years old aOR = 6.23 (4.73–8.19); 45–54 years old aOR = 3.87 (2.92–5.14); and 55–64 years old aOR = 2.58 (1.96–3.38)), income ($15,000–$24,999 aOR = 1.00 (0.63–1.58); $25,000–$34,999 aOR = 1.61 (1.04–2.50); $35,000-$49,999 aOR = 1.69 (1.13–2.55); ≥$50,000 aOR = 1.97 (1.34–2.89)), smokeless tobacco use (aOR = 2.09 (1.55–2.82)), and smoking/e-cigarette use (Cigarette user only aOR = 2.11 (1.69–2.65); E-cigarette user only aOR = 2.67 (1.62–3.17); dual cigarette and e-cigarette user = 3.43 (2.21–5.33)). Conclusion: Developing interventions that take into account elevated risk for binge drinking amongst demographic characteristics (i.e., age, sex, income) and lifestyle factors (i.e., smokeless tobacco use, and smoking/e-cigarette use) is crucial to lowering morbidity and mortality related to this form of excessive alcohol consumption.
背景:在美国,20-64岁的成年人中,十分之一的人死于过度饮酒。酗酒是一种常见的过度饮酒形式,导致了这一令人不寒而栗的统计数据。酗酒的定义是女性在2小时内喝4杯或以上,男性喝5杯或以上。检查酗酒风险因素的现有数据可以为预防这种致命行为的策略提供信息。方法:2019年堪萨斯州行为风险因素监测系统(BRFSS)数据集包括从11,368名18岁及以上使用固定电话或手机的非机构成年人收集的数据。本研究的因变量是酗酒状况。自变量包括几个社会人口变量和危险因素。数据分析采用描述性统计、双变量分析、单变量逻辑回归和多变量逻辑回归。结果:在人群中,1447人(17.4%)被报告为酗酒者。最终模型中与酗酒相关的显著因素包括性别(aOR = 0.53(0.45-0.63))、年龄(18-24岁aOR = 8.77 (6.02-12.79);25 ~ 34岁aOR = 7.10 (5.35 ~ 9.42);35 ~ 44岁aOR = 6.23 (4.73 ~ 8.19);45 ~ 54岁aOR = 3.87 (2.92 ~ 5.14);55-64岁aOR = 2.58(1.96-3.38)),收入($15,000 - $24,999 aOR = 1.00 (0.63-1.58);$25,000 - $34,999 aOR = 1.61 (1.04-2.50);$35,000-$49,999 aOR = 1.69 (1.13-2.55);≥50,000美元aOR = 1.97(1.34-2.89)),无烟烟草使用(aOR = 2.09(1.55-2.82)),吸烟/电子烟使用(仅吸烟的aOR = 2.11 (1.69-2.65);仅使用电子烟的aOR = 2.67 (1.62-3.17);双烟和电子烟用户= 3.43(2.21-5.33))。结论:制定干预措施,考虑人口统计学特征(即年龄、性别、收入)和生活方式因素(即无烟烟草使用和吸烟/电子烟使用)中酗酒风险的增加,对于降低与这种形式的过度饮酒相关的发病率和死亡率至关重要。
{"title":"Factors Associated with Binge Drinking—Findings from 2019 Kansas Behavioral Risk Factor Surveillance System","authors":"S. Lines, Aliya Marroquin, Steve Corbett, Julie Sergeant, Won Choi, B. Faseru","doi":"10.1080/08897077.2022.2060437","DOIUrl":"https://doi.org/10.1080/08897077.2022.2060437","url":null,"abstract":"Background: In the U.S., excessive drinking accounts for one in 10 deaths among adults aged 20–64 years old. Binge drinking is a common form of excessive alcohol consumption that contributes to this chilling statistic. Binge drinking is defined as women consuming four or more drinks or men consuming five or more drinks within a 2-h time span. Examining existing data on risk factors for binge drinking can inform strategies to prevent this deadly practice. Methods: The 2019 Kansas Behavioral Risk Factor Surveillance System (BRFSS) dataset consists of data collected from 11,368 non-institutionalized adults aged 18 years and older with landline or cell phones. The dependent variable in this study was binge drinking status. The independent variables included several sociodemographic variables and risk factors. Data were analyzed using descriptive statistics, bivariate analysis, single logistic regression, and multivariable logistic regression. Results: In the population, 1,447 (17.4%) were reported to be binge drinkers. Significant factors associated with binge drinking in the final model included sex (aOR = 0.53 (0.45–0.63)), age (18–24 years old aOR = 8.77 (6.02–12.79); 25–34 years old aOR = 7.10 (5.35–9.42); 35–44 years old aOR = 6.23 (4.73–8.19); 45–54 years old aOR = 3.87 (2.92–5.14); and 55–64 years old aOR = 2.58 (1.96–3.38)), income ($15,000–$24,999 aOR = 1.00 (0.63–1.58); $25,000–$34,999 aOR = 1.61 (1.04–2.50); $35,000-$49,999 aOR = 1.69 (1.13–2.55); ≥$50,000 aOR = 1.97 (1.34–2.89)), smokeless tobacco use (aOR = 2.09 (1.55–2.82)), and smoking/e-cigarette use (Cigarette user only aOR = 2.11 (1.69–2.65); E-cigarette user only aOR = 2.67 (1.62–3.17); dual cigarette and e-cigarette user = 3.43 (2.21–5.33)). Conclusion: Developing interventions that take into account elevated risk for binge drinking amongst demographic characteristics (i.e., age, sex, income) and lifestyle factors (i.e., smokeless tobacco use, and smoking/e-cigarette use) is crucial to lowering morbidity and mortality related to this form of excessive alcohol consumption.","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48130658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluation of U.S. State Opioid Prescribing Restrictions Using Patient Opioid Consumption Patterns from A Single, Urban, Academic Institution 从单个城市学术机构使用患者阿片类药物消费模式评估美国州阿片类药物处方限制
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-04-11 DOI: 10.1080/08897077.2022.2056934
K. Robinson, J. Marwaha, Chris J. Kennedy, B. Beaulieu-Jones, A. Fleishman, Justin Yu, L. Nathanson, G. Brat
Background:Since 2017, states, insurers, and pharmacies have placed blanket limits on the duration and quantity of opioid prescriptions. In many states, overlapping duration and daily dose limits yield maximum prescription limits of 150–350 morphine milligram equivalents (MMEs). There is limited knowledge of how these restrictions compare with actual patient opioid consumption; while changes in prescription patterns and opioid misuse rates have been studied, these are, at best, weak proxies for actual pain control consumption. We sought to determine how patients undergoing surgery would be affected by opioid prescribing restrictions using actual patient opioid consumption data. Methods: We constructed a prospective database of post-discharge opioid consumption: patients undergoing surgery at one institution were called after discharge to collect opioid consumption data. Patients whose opioid consumption exceeded 150 and 350 MME were identified. Results: Two thousand nine hundred and seventy-one patients undergoing 54 common surgical procedures were included in our study. Twenty-one percent of patients consumed more than the 150 MME limit. Only 7% of patients consumed above the 350 MME limit. Typical (non-outlier) opioid consumption, defined as less than the 75th percentile of consumption for any given procedure, exceeded the 150 MME and 350 MME limits for 41 and 7% of procedures, respectively. Orthopedic, spinal/neurosurgical, and complex abdominal procedures most commonly exceeded these limits. Conclusions: While most patients undergoing surgery are unaffected by recent blanket prescribing limits, those undergoing a specific subset of procedures are likely to require more opioids than the restrictions permit; providers should be aware that these patients may require a refill to adequately control post-surgical pain. Real consumption data should be used to guide these restrictions and inform future interventions so the risk of worsened pain control (and its troublesome effects on opioid misuse) is minimized. Procedure-specific prescribing limits may be one approach to prevent misuse, while also optimizing post-operative pain control.
背景:自2017年以来,各州、保险公司和药店对阿片类药物处方的持续时间和数量进行了全面限制。在许多州,重叠的持续时间和每日剂量限制导致最高处方限制为150-350吗啡毫克当量(MMEs)。对于这些限制与实际患者阿片类药物消费量的比较,我们了解有限;虽然已经研究了处方模式和阿片类药物滥用率的变化,但这些充其量只是实际疼痛控制消费的弱代表。我们试图通过使用实际患者阿片类药物消费数据来确定接受手术的患者如何受到阿片类药物处方限制的影响。方法:我们构建了一个出院后阿片类药物消费的前瞻性数据库:在一家机构接受手术的患者出院后被称为收集阿片类药物消费数据。确定阿片类药物消耗量超过150和350 MME的患者。结果:我们的研究纳入了接受54种常见外科手术的2,971例患者。21%的患者摄入了超过150mme的限制。只有7%的患者摄入超过350mme的限制。典型(非异常值)阿片类药物消费量,定义为任何给定程序的消费量低于第75百分位数,分别超过41%和7%的程序的150 MME和350 MME限制。骨科、脊柱/神经外科和复杂的腹部手术最常超过这些限制。结论:虽然大多数接受手术的患者不受最近的一揽子处方限制的影响,但接受特定手术子集的患者可能需要比限制允许更多的阿片类药物;提供者应该意识到这些患者可能需要重新补充以充分控制术后疼痛。应该使用真实的消费数据来指导这些限制,并为未来的干预提供信息,以便将疼痛控制恶化的风险(及其对阿片类药物滥用的麻烦影响)降至最低。特定程序的处方限制可能是防止滥用的一种方法,同时也优化了术后疼痛控制。
{"title":"Evaluation of U.S. State Opioid Prescribing Restrictions Using Patient Opioid Consumption Patterns from A Single, Urban, Academic Institution","authors":"K. Robinson, J. Marwaha, Chris J. Kennedy, B. Beaulieu-Jones, A. Fleishman, Justin Yu, L. Nathanson, G. Brat","doi":"10.1080/08897077.2022.2056934","DOIUrl":"https://doi.org/10.1080/08897077.2022.2056934","url":null,"abstract":"Background:Since 2017, states, insurers, and pharmacies have placed blanket limits on the duration and quantity of opioid prescriptions. In many states, overlapping duration and daily dose limits yield maximum prescription limits of 150–350 morphine milligram equivalents (MMEs). There is limited knowledge of how these restrictions compare with actual patient opioid consumption; while changes in prescription patterns and opioid misuse rates have been studied, these are, at best, weak proxies for actual pain control consumption. We sought to determine how patients undergoing surgery would be affected by opioid prescribing restrictions using actual patient opioid consumption data. Methods: We constructed a prospective database of post-discharge opioid consumption: patients undergoing surgery at one institution were called after discharge to collect opioid consumption data. Patients whose opioid consumption exceeded 150 and 350 MME were identified. Results: Two thousand nine hundred and seventy-one patients undergoing 54 common surgical procedures were included in our study. Twenty-one percent of patients consumed more than the 150 MME limit. Only 7% of patients consumed above the 350 MME limit. Typical (non-outlier) opioid consumption, defined as less than the 75th percentile of consumption for any given procedure, exceeded the 150 MME and 350 MME limits for 41 and 7% of procedures, respectively. Orthopedic, spinal/neurosurgical, and complex abdominal procedures most commonly exceeded these limits. Conclusions: While most patients undergoing surgery are unaffected by recent blanket prescribing limits, those undergoing a specific subset of procedures are likely to require more opioids than the restrictions permit; providers should be aware that these patients may require a refill to adequately control post-surgical pain. Real consumption data should be used to guide these restrictions and inform future interventions so the risk of worsened pain control (and its troublesome effects on opioid misuse) is minimized. Procedure-specific prescribing limits may be one approach to prevent misuse, while also optimizing post-operative pain control.","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42143256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Satisfaction with Group-Based Appointments among Patients with Opioid Use Disorder in An Urban Buprenorphine Clinic 城市丁丙诺啡门诊阿片类药物使用障碍患者对团体预约的满意度
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-02-28 DOI: 10.1080/08897077.2021.2010258
Serra Akyar, Amesika N. Nyaku, Kristyn Lao, Stephanie Ruthberg, Erin Zerbo
Background: Successful implementation of group-based appointments can increase capacity to treat patients, reduce costs, and improve productivity. We sought to understand the acceptability of group-based appointments for opioid use disorder (OUD) in an urban clinical setting that treats predominantly ethnic minority populations. Methods: A survey collecting data on demographics, substance use, co-morbid psychiatric conditions, and satisfaction with group-based opioid treatment (GBOT) was conducted among patients 18 years and older with OUD attending an urban buprenorphine clinic between December 2019 and February 2020. Results: Thirty-nine patient surveys were completed. Among participants, 64.1% identified as Black/African American and 76.9% identified as male. The mean age was 51.2 years. Participants reported overall high levels of satisfaction with group-based appointments though GBOT was not strongly preferred over individual visits. On a 5-point Likert scale, 69.2% of participants agreed or strongly agreed that their medical needs were met during group-based appointments. A majority of participants agreed or strongly agreed that medical information received from the clinical team (97.4%) and other patients (82.1%) were valuable. Most participants (82.1%) reported adherence to treatment plans became easier since attending GBOT. Age and self-identified employment status as disabled or retired were positively associated with total satisfaction scores. Conclusions: Patients in a predominantly Black/African American and Hispanic/Latinx community with co-occurring mental health disorders and other substance use reported overall satisfaction with GBOT and would recommend this modality to other patients.
背景:成功实施基于小组的预约可以提高治疗患者的能力,降低成本,提高生产力。我们试图了解在主要治疗少数民族人群的城市临床环境中,基于群体的阿片类药物使用障碍(OUD)预约的可接受性。方法:对18名患者进行了一项调查,收集了人口统计学、药物使用、共病精神状况和对基于群体的阿片类药物治疗(GBOT)的满意度的数据 2019年12月至2020年2月期间,岁及以上OUD患者在城市丁丙诺啡诊所就诊。结果:完成了39项患者调查。在参与者中,64.1%被认定为黑人/非裔美国人,76.9%被认定为男性。平均年龄51.2岁 年。参与者报告称,尽管GBOT并不比个人访问更受欢迎,但他们对团体预约的总体满意度很高。在5分的Likert量表中,69.2%的参与者同意或强烈同意他们的医疗需求在基于小组的预约中得到了满足。大多数参与者同意或强烈同意从临床团队(97.4%)和其他患者(82.1%)收到的医疗信息是有价值的。大多数参与者(82.1%)表示,自从参加GBOT后,遵守治疗计划变得更容易了。年龄和自我认定的残疾或退休就业状况与总满意度得分呈正相关。结论:在以黑人/非裔美国人和西班牙裔/拉丁裔为主的社区中,同时患有精神健康障碍和其他药物使用的患者报告了对GBOT的总体满意度,并将向其他患者推荐这种模式。
{"title":"Satisfaction with Group-Based Appointments among Patients with Opioid Use Disorder in An Urban Buprenorphine Clinic","authors":"Serra Akyar, Amesika N. Nyaku, Kristyn Lao, Stephanie Ruthberg, Erin Zerbo","doi":"10.1080/08897077.2021.2010258","DOIUrl":"https://doi.org/10.1080/08897077.2021.2010258","url":null,"abstract":"Background: Successful implementation of group-based appointments can increase capacity to treat patients, reduce costs, and improve productivity. We sought to understand the acceptability of group-based appointments for opioid use disorder (OUD) in an urban clinical setting that treats predominantly ethnic minority populations. Methods: A survey collecting data on demographics, substance use, co-morbid psychiatric conditions, and satisfaction with group-based opioid treatment (GBOT) was conducted among patients 18 years and older with OUD attending an urban buprenorphine clinic between December 2019 and February 2020. Results: Thirty-nine patient surveys were completed. Among participants, 64.1% identified as Black/African American and 76.9% identified as male. The mean age was 51.2 years. Participants reported overall high levels of satisfaction with group-based appointments though GBOT was not strongly preferred over individual visits. On a 5-point Likert scale, 69.2% of participants agreed or strongly agreed that their medical needs were met during group-based appointments. A majority of participants agreed or strongly agreed that medical information received from the clinical team (97.4%) and other patients (82.1%) were valuable. Most participants (82.1%) reported adherence to treatment plans became easier since attending GBOT. Age and self-identified employment status as disabled or retired were positively associated with total satisfaction scores. Conclusions: Patients in a predominantly Black/African American and Hispanic/Latinx community with co-occurring mental health disorders and other substance use reported overall satisfaction with GBOT and would recommend this modality to other patients.","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48497017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Rates of Discontinuation and Non-Publication of Trials for the Pharmacologic Treatment of Alcohol Use Disorder 药物治疗酒精使用障碍试验的中止率和未发表率
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-02-28 DOI: 10.1080/08897077.2021.2010261
M. Hartwell, Nicholas B. Sajjadi, Samuel Shepard, John Whelan, Jamie N. Roberts, A. Ford, J. Beaman, M. Vassar
Objective:With approximately 15 million individuals in the United States meeting criteria for Alcohol Use Disorder (AUD), advancing effective medication-assisted treatment options is crucial. This advancement stems from the publication of clinical trial (CT) results. The primary objective of this study was to assess the rates of discontinuation and non-publication of results in CTs focused on the pharmacologic treatment of AUD and to assess associated factors. Design: A cross-sectional study was completed after acquiring trials focused on AUD within the ClinicalTrials.gov database. Inclusion criteria for CTs were the use of a pharmaceutical intervention with an outcome measure of alcohol intake or craving, conducted between October 2008 through September 2018. The primary outcome measures were the frequency of trial discontinuation and non-publication. Discontinuation was assessed as the listed status on ClinicalTrials.gov. Publications were identified through verification of listings on ClinicalTrials.gov, or via searches of PubMed, Embase, and Google Scholar. If publications were not found, correspondence to trial contacts were sent. Data analysis occurred on December 5th, 2020. Results: Of 235 trials returned from the search, 87 met inclusion criteria. Our study found that 12.6% (11) of CTs involving pharmaceutical treatments for AUD were prematurely terminated, and 39.1% (34) had no published results. Recruitment and lower cutoff of targeted age groups were significantly associated with discontinuation and non-publication, respectively. Conclusions: Scientific evidence advances faster when all results are known—furthering the progress of positive studies, while avoiding duplicative efforts to test the same hypotheses with the same methods, thereby reducing scientific waste. Given the number of unpublished AUD trials, potentially useful information regarding treatment for individuals with AUD may be inaccessible to clinicians while also adding to the abundance of research waste. Key points Question: What are the rates of discontinuation or non-publication of clinical trials for pharmacological treatments for AUD and associated factors? Findings: Among 87 trials, 11 (12.6%) were prematurely terminated and 34 (39.1%) did not reach publication, with trials that included participants 21 years and older more likely to reach publication than those with younger participants. Meaning: Low publication rates of CTs for pharmacological treatments of AUD may (1) stunt the advancement of AUD research, (2) decrease the value in funding AUD research from government entities, and (3) needlessly expose participants to potentially harmful interventions.
目的:美国约有1500万人符合酒精使用障碍(AUD)的标准,推进有效的药物辅助治疗方案至关重要。这一进展源于临床试验(CT)结果的公布。本研究的主要目的是评估以AUD药物治疗为重点的CT的停药率和未公布结果,并评估相关因素。设计:在ClinicalTrials.gov数据库中获得专注于AUD的试验后,完成了一项横断面研究。CT的纳入标准是在2008年10月至2018年9月期间进行的药物干预,并对酒精摄入或渴望进行结果测量。主要的结果指标是试验中止和未发表的频率。停刊被评估为ClinicalTrials.gov上的列表状态。出版物是通过验证ClinicalTrials.gov上列表或通过搜索PubMed、Embase和Google Scholar来确定的。如果没有找到出版物,就向审判联系人发送信件。数据分析发生在2020年12月5日。结果:在搜索返回的235项试验中,87项符合入选标准。我们的研究发现,12.6%(11)涉及AUD药物治疗的CT提前终止,39.1%(34)没有公布结果。招募和目标年龄组的下限分别与停药和不发表显著相关。结论:当所有结果都已知时,科学证据进展得更快——进一步推动了积极研究的进展,同时避免了用相同的方法测试相同假设的重复努力,从而减少了科学浪费。鉴于未发表的AUD试验的数量,临床医生可能无法获得有关AUD患者治疗的潜在有用信息,同时也增加了大量的研究浪费。要点问题:AUD药物治疗及相关因素的临床试验中止或未发表的比率是多少?研究结果:在87项试验中,11项(12.6%)过早终止,34项(39.1%)未发表,包括21岁及以上参与者的试验比年轻参与者更有可能发表。含义:AUD药物治疗的CT发表率低可能(1)阻碍AUD研究的进展,(2)降低政府实体资助AUD研究价值,以及(3)使参与者不必要地暴露于潜在的有害干预措施中。
{"title":"Rates of Discontinuation and Non-Publication of Trials for the Pharmacologic Treatment of Alcohol Use Disorder","authors":"M. Hartwell, Nicholas B. Sajjadi, Samuel Shepard, John Whelan, Jamie N. Roberts, A. Ford, J. Beaman, M. Vassar","doi":"10.1080/08897077.2021.2010261","DOIUrl":"https://doi.org/10.1080/08897077.2021.2010261","url":null,"abstract":"Objective:With approximately 15 million individuals in the United States meeting criteria for Alcohol Use Disorder (AUD), advancing effective medication-assisted treatment options is crucial. This advancement stems from the publication of clinical trial (CT) results. The primary objective of this study was to assess the rates of discontinuation and non-publication of results in CTs focused on the pharmacologic treatment of AUD and to assess associated factors. Design: A cross-sectional study was completed after acquiring trials focused on AUD within the ClinicalTrials.gov database. Inclusion criteria for CTs were the use of a pharmaceutical intervention with an outcome measure of alcohol intake or craving, conducted between October 2008 through September 2018. The primary outcome measures were the frequency of trial discontinuation and non-publication. Discontinuation was assessed as the listed status on ClinicalTrials.gov. Publications were identified through verification of listings on ClinicalTrials.gov, or via searches of PubMed, Embase, and Google Scholar. If publications were not found, correspondence to trial contacts were sent. Data analysis occurred on December 5th, 2020. Results: Of 235 trials returned from the search, 87 met inclusion criteria. Our study found that 12.6% (11) of CTs involving pharmaceutical treatments for AUD were prematurely terminated, and 39.1% (34) had no published results. Recruitment and lower cutoff of targeted age groups were significantly associated with discontinuation and non-publication, respectively. Conclusions: Scientific evidence advances faster when all results are known—furthering the progress of positive studies, while avoiding duplicative efforts to test the same hypotheses with the same methods, thereby reducing scientific waste. Given the number of unpublished AUD trials, potentially useful information regarding treatment for individuals with AUD may be inaccessible to clinicians while also adding to the abundance of research waste. Key points Question: What are the rates of discontinuation or non-publication of clinical trials for pharmacological treatments for AUD and associated factors? Findings: Among 87 trials, 11 (12.6%) were prematurely terminated and 34 (39.1%) did not reach publication, with trials that included participants 21 years and older more likely to reach publication than those with younger participants. Meaning: Low publication rates of CTs for pharmacological treatments of AUD may (1) stunt the advancement of AUD research, (2) decrease the value in funding AUD research from government entities, and (3) needlessly expose participants to potentially harmful interventions.","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47659542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Predictors and moderators of response to brief interventions among adolescents with risky alcohol and marijuana use. 有酗酒和吸食大麻风险的青少年对简短干预反应的预测因素和调节因素。
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-01-01 Epub Date: 2020-03-24 DOI: 10.1080/08897077.2020.1742271
Sara J Becker, Kristine Marceau, Sarah A Helseth, Lynn Hernandez, Anthony Spirito

Background:Brief interventions have shown promise in reducing adolescent alcohol and marijuana use. This manuscript presents a secondary analysis of a randomized trial that compared a brief parent motivational intervention (Family Check Up; FCU) to brief psychoeducation (PE) condition and found no effect of treatment condition on either binge drinking or marijuana use days. The current analyses explored whether the response to treatment may have varied as a function of six empirically-based baseline moderators and predictors: biological sex, age, race/ethnicity, mental health problems, parent-adolescent communication, and peer deviance. Methods: Data from the parent trial randomizing 102 parents to either the FCU (n = 51) or PE (n = 51) interventions were re-analyzed across four time points (baseline, 3-, 6-, and 12-months). Moderators and predictors were tested via a series of hierarchical linear models. Results: Parent-adolescent communication and peer deviance emerged as significant predictors of adolescent treatment response. Specifically, low-levels of parent-adolescent communication or peer deviance were associated with worse treatment response (i.e., significant increases in binge drinking days and marijuana use days) in the PE condition, but not in the FCU condition. Non-Hispanic Whites and girls had worse treatment response, regardless of treatment condition. Conclusions: The FCU condition appeared to mitigate risks of poor parent-adolescent communication and affiliation with deviant peers better than the PE condition. Clinical recommendations for decision-making around assignment to brief interventions are discussed.

背景:简短干预在减少青少年酗酒和吸食大麻方面取得了良好效果。本手稿对一项随机试验进行了二次分析,该试验比较了简短的家长激励干预(Family Check Up;FCU)和简短的心理教育(PE)条件,结果发现治疗条件对暴饮或吸食大麻天数均无影响。目前的分析探讨了对治疗的反应是否会因以下六个基于经验的基线调节因素和预测因素而有所不同:生理性别、年龄、种族/民族、心理健康问题、父母与青少年的沟通以及同伴偏差。研究方法在四个时间点(基线、3 个月、6 个月和 12 个月)上,对 102 名家长随机接受 FCU(51 人)或 PE(51 人)干预的试验数据进行了重新分析。通过一系列分层线性模型对调节因素和预测因素进行了检验。结果如下父母与青少年之间的沟通和同伴间的偏差成为青少年治疗反应的重要预测因素。具体来说,在 PE 条件下,低水平的父母与青少年沟通或同伴偏差与治疗反应较差有关(即暴饮暴食天数和吸食大麻天数显著增加),但在 FCU 条件下则无关。非西班牙裔白人和女孩的治疗反应较差,与治疗条件无关。结论:家庭、学校和社区 "条件似乎比 "体育 "条件更能减轻父母与青少年沟通不畅以及与不正常同伴交往的风险。本文还讨论了关于简短干预决策的临床建议。
{"title":"Predictors and moderators of response to brief interventions among adolescents with risky alcohol and marijuana use.","authors":"Sara J Becker, Kristine Marceau, Sarah A Helseth, Lynn Hernandez, Anthony Spirito","doi":"10.1080/08897077.2020.1742271","DOIUrl":"10.1080/08897077.2020.1742271","url":null,"abstract":"<p><p><i>Background:</i>Brief interventions have shown promise in reducing adolescent alcohol and marijuana use. This manuscript presents a secondary analysis of a randomized trial that compared a brief parent motivational intervention (Family Check Up; FCU) to brief psychoeducation (PE) condition and found no effect of treatment condition on either binge drinking or marijuana use days. The current analyses explored whether the response to treatment may have varied as a function of six empirically-based baseline moderators and predictors: biological sex, age, race/ethnicity, mental health problems, parent-adolescent communication, and peer deviance. <i>Methods:</i> Data from the parent trial randomizing 102 parents to either the FCU (<i>n</i> = 51) or PE (<i>n</i> = 51) interventions were re-analyzed across four time points (baseline, 3-, 6-, and 12-months). Moderators and predictors were tested via a series of hierarchical linear models. <i>Results:</i> Parent-adolescent communication and peer deviance emerged as significant predictors of adolescent treatment response. Specifically, low-levels of parent-adolescent communication or peer deviance were associated with worse treatment response (i.e., significant <i>increases</i> in binge drinking days and marijuana use days) in the PE condition, but not in the FCU condition. Non-Hispanic Whites and girls had worse treatment response, regardless of treatment condition. <i>Conclusions:</i> The FCU condition appeared to mitigate risks of poor parent-adolescent communication and affiliation with deviant peers better than the PE condition. Clinical recommendations for decision-making around assignment to brief interventions are discussed.</p>","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08897077.2020.1742271","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10455957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Familial support in integrated treatment with antiretroviral therapy and medications for opioid use disorder in Vietnam: A qualitative study. 在越南,抗逆转录病毒治疗和阿片类药物使用障碍综合治疗中的家庭支持:一项定性研究。
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-01-01 DOI: 10.1080/08897077.2022.2060435
Patrick C M Brown, Thị Thanh Thuy Dinh, Andrew Edsall, Thu Hang Nguyen, Pham Phuong Mai, Kim Hoffman, Gavin Bart, P Todd Korthuis, Minh Giang Le

Background: Patients report that familial support can facilitate initiation and maintenance of antiretroviral therapy (ART) and medications for opioid use disorder (MOUD). However, providing such support can create pressure and additional burdens for families of people with opioid use disorder (OUD) and HIV. We examined perspectives of people with HIV receiving treatment for OUD in Vietnam and their family members. Methods: Between 2015 and 2018, we conducted face-to-face qualitative interviews with 44 patients and 30 of their family members in Hanoi, Vietnam. Participants were people living with HIV and OUD enrolled in the BRAVO study comparing HIV clinic-based buprenorphine with referral to methadone treatment at 4 HIV clinics and their immediate family members (spouses or parents). Interviews were professionally transcribed, coded in Vietnamese, and analyzed using a semantic, inductive approach to qualitative thematic analysis. Results: Family members of people with OUD and HIV in Vietnam reported financially and emotionally supporting MOUD initiation and maintenance as well as actively participating in treatment. Family members described the burdens of supporting patients during opioid use, including financial costs and secondary stigma. Conclusions: Describing the role of family support in the lives of people living with OUD and HIV in the context of Vietnam enriches our understanding of their experiences and will support future treatment efforts targeting the family unit.

背景:患者报告家庭支持可以促进抗逆转录病毒治疗(ART)和阿片类药物使用障碍(mod)药物的开始和维持。然而,提供这种支持可能会给阿片类药物使用障碍和艾滋病毒患者的家庭带来压力和额外负担。我们研究了越南接受OUD治疗的HIV感染者及其家庭成员的观点。方法:2015年至2018年,我们对越南河内的44名患者及其30名家属进行了面对面的定性访谈。参与者是BRAVO研究的HIV和OUD感染者,他们比较了4家HIV诊所的丁丙诺啡和美沙酮治疗的转诊,以及他们的直系亲属(配偶或父母)。访谈经过专业转录,以越南语编码,并使用语义,归纳方法进行定性主题分析。结果:越南的OUD和HIV患者的家庭成员在经济上和情感上支持mud的启动和维持,并积极参与治疗。家庭成员描述了在阿片类药物使用期间支持患者的负担,包括经济成本和继发耻辱。结论:在越南的背景下,描述家庭支持在OUD和HIV患者生活中的作用丰富了我们对他们经历的理解,并将支持未来针对家庭单位的治疗工作。
{"title":"Familial support in integrated treatment with antiretroviral therapy and medications for opioid use disorder in Vietnam: A qualitative study.","authors":"Patrick C M Brown,&nbsp;Thị Thanh Thuy Dinh,&nbsp;Andrew Edsall,&nbsp;Thu Hang Nguyen,&nbsp;Pham Phuong Mai,&nbsp;Kim Hoffman,&nbsp;Gavin Bart,&nbsp;P Todd Korthuis,&nbsp;Minh Giang Le","doi":"10.1080/08897077.2022.2060435","DOIUrl":"https://doi.org/10.1080/08897077.2022.2060435","url":null,"abstract":"<p><p><i>Background</i>: Patients report that familial support can facilitate initiation and maintenance of antiretroviral therapy (ART) and medications for opioid use disorder (MOUD). However, providing such support can create pressure and additional burdens for families of people with opioid use disorder (OUD) and HIV. We examined perspectives of people with HIV receiving treatment for OUD in Vietnam and their family members. <i>Methods</i>: Between 2015 and 2018, we conducted face-to-face qualitative interviews with 44 patients and 30 of their family members in Hanoi, Vietnam. Participants were people living with HIV and OUD enrolled in the BRAVO study comparing HIV clinic-based buprenorphine with referral to methadone treatment at 4 HIV clinics and their immediate family members (spouses or parents). Interviews were professionally transcribed, coded in Vietnamese, and analyzed using a semantic, inductive approach to qualitative thematic analysis. <i>Results</i>: Family members of people with OUD and HIV in Vietnam reported financially and emotionally supporting MOUD initiation and maintenance as well as actively participating in treatment. Family members described the burdens of supporting patients during opioid use, including financial costs and secondary stigma. <i>Conclusions</i>: Describing the role of family support in the lives of people living with OUD and HIV in the context of Vietnam enriches our understanding of their experiences and will support future treatment efforts targeting the family unit.</p>","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678077/pdf/nihms-1842162.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10457844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Disparities in receipt of medications for opioid use disorder among pregnant women. 孕妇接受阿片类药物使用障碍药物治疗的差异。
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-01-01 DOI: 10.1080/08897077.2021.1949664
Laura E Henkhaus, Melinda B Buntin, Sarah Clark Henderson, Pikki Lai, Stephen W Patrick

Background: Medications for opioid use disorder (MOUD) improve outcomes for pregnant women and infants. Our primary aim was to examine disparities in maternal MOUD receipt by family sociodemographic characteristics. Methods: This retrospective cohort study included mother-infant dyads with Medicaid-covered deliveries in Tennessee from 2009 to 2016. First, we examined family sociodemographic characteristics - including race/ethnicity, rurality, mother's primary language and education level, and whether paternity was recorded in birth records - and newborn outcomes by type of maternal opioid use. Second, among pregnant women with OUD, we used logistic regression to measure disparities in receipt of MOUD by family sociodemographic characteristics including interactions between characteristics. Results: Our cohort from Medicaid-covered deliveries consisted of 314,965 mother-infant dyads, and 4.2 percent were exposed to opioids through maternal use. Among dyads with maternal OUD, MOUD receipt was associated with lower rates of preterm and very preterm birth. Logistic regression adjusted for family sociodemographic characteristics showed that pregnant women with OUD in rural versus urban areas (aOR: 0.66; 95% CI: 0.60-0.72) and who were aged ≥35 years versus ≤25 years (aOR: 0.75; 95% CI: 0.64-0.89) were less likely to have received MOUD. Families in which the mother's primary language was English (aOR: 2.47; 95% CI: 1.24-4.91) and paternity was recorded on the birth certificate (aOR: 1.30; 95% CI: 1.19-1.42) were more likely to have received MOUD. Regardless of high school degree attainment, non-Hispanic Black versus non-Hispanic White race was associated with lower likelihood of MOUD receipt. Hispanic race was associated with lower likelihood of MOUD receipt among women without a high school degree. Conclusions: Among a large cohort of pregnant women, we found disparities in receipt of MOUD among non-Hispanic Black, Hispanic, and rural pregnant women. As policymakers consider strategies to improve access to MOUD, they should consider targeted approaches to address these disparities.

背景:阿片类药物使用障碍(mod)改善孕妇和婴儿的结局。我们的主要目的是通过家庭社会人口学特征来检查产妇接受mod的差异。方法:本回顾性队列研究包括2009年至2016年在田纳西州分娩的有医疗补助的母婴。首先,我们检查了家庭社会人口特征——包括种族/民族、农村、母亲的主要语言和教育水平,以及出生记录中是否记录了父亲的身份——以及按母亲使用阿片类药物类型划分的新生儿结局。其次,在患有OUD的孕妇中,我们使用逻辑回归来衡量家庭社会人口学特征(包括特征之间的相互作用)在接受OUD方面的差异。结果:我们的队列来自医疗保险覆盖的分娩,包括314,965对母婴,其中4.2%通过母亲使用阿片类药物暴露。在母亲患有OUD的二人组中,mod接受与较低的早产和非常早产率相关。经家庭社会人口学特征调整后的Logistic回归显示,农村孕妇与城市孕妇相比(aOR: 0.66;95% CI: 0.60-0.72),年龄≥35岁vs≤25岁(aOR: 0.75;95% CI: 0.64-0.89)接受mod的可能性较小。母亲以英语为主要语言的家庭(aOR: 2.47;95% CI: 1.24-4.91),出生证明上记录了父亲的身份(aOR: 1.30;95% CI: 1.19-1.42)更有可能接受mod。无论高中学历如何,非西班牙裔黑人与非西班牙裔白人相比,接受mod的可能性较低。西班牙裔与没有高中学历的女性接受mod的可能性较低有关。结论:在大量孕妇队列中,我们发现非西班牙裔黑人、西班牙裔和农村孕妇接受mod的差异。在决策者考虑改善mod获取的战略时,他们应该考虑有针对性的方法来解决这些差异。
{"title":"Disparities in receipt of medications for opioid use disorder among pregnant women.","authors":"Laura E Henkhaus,&nbsp;Melinda B Buntin,&nbsp;Sarah Clark Henderson,&nbsp;Pikki Lai,&nbsp;Stephen W Patrick","doi":"10.1080/08897077.2021.1949664","DOIUrl":"https://doi.org/10.1080/08897077.2021.1949664","url":null,"abstract":"<p><p><i>Background</i>: Medications for opioid use disorder (MOUD) improve outcomes for pregnant women and infants. Our primary aim was to examine disparities in maternal MOUD receipt by family sociodemographic characteristics. <i>Methods</i>: This retrospective cohort study included mother-infant dyads with Medicaid-covered deliveries in Tennessee from 2009 to 2016. First, we examined family sociodemographic characteristics - including race/ethnicity, rurality, mother's primary language and education level, and whether paternity was recorded in birth records - and newborn outcomes by type of maternal opioid use. Second, among pregnant women with OUD, we used logistic regression to measure disparities in receipt of MOUD by family sociodemographic characteristics including interactions between characteristics. <i>Results</i>: Our cohort from Medicaid-covered deliveries consisted of 314,965 mother-infant dyads, and 4.2 percent were exposed to opioids through maternal use. Among dyads with maternal OUD, MOUD receipt was associated with lower rates of preterm and very preterm birth. Logistic regression adjusted for family sociodemographic characteristics showed that pregnant women with OUD in rural versus urban areas (aOR: 0.66; 95% CI: 0.60-0.72) and who were aged ≥35 years versus ≤25 years (aOR: 0.75; 95% CI: 0.64-0.89) were less likely to have received MOUD. Families in which the mother's primary language was English (aOR: 2.47; 95% CI: 1.24-4.91) and paternity was recorded on the birth certificate (aOR: 1.30; 95% CI: 1.19-1.42) were more likely to have received MOUD. Regardless of high school degree attainment, non-Hispanic Black versus non-Hispanic White race was associated with lower likelihood of MOUD receipt. Hispanic race was associated with lower likelihood of MOUD receipt among women without a high school degree. <i>Conclusions</i>: Among a large cohort of pregnant women, we found disparities in receipt of MOUD among non-Hispanic Black, Hispanic, and rural pregnant women. As policymakers consider strategies to improve access to MOUD, they should consider targeted approaches to address these disparities.</p>","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08897077.2021.1949664","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10694843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Perceptions on navigating ACGME-accredited addiction psychiatry fellowship program websites: A thematic analysis across a race- and gender-diverse pool of potential applicants. 浏览acgme认证的成瘾精神病学奖学金项目网站的看法:跨种族和性别多样化潜在申请人的主题分析。
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-01-01 DOI: 10.1080/08897077.2022.2028703
Matthew P Abrams, Danielle S Jackson, Amaka Aneke-Gratia, Anne E Kohler, Nicky Mehtani, Ayana Jordan

Background: There is an alarming shortage of addiction psychiatrists in the United States. To promote interest in addiction psychiatry (ADP), it is essential to maximize resources available through ADP fellowship websites. The aim of this study was to investigate the perceived adequacy and accessibility of content on ADP fellowship websites and discover what further information is considered important among trainees interested in becoming addiction specialists. Methods: Three virtual focus groups were conducted between January and February 2021 among medical students and residents in diverse geographic regions. Participants were asked about the availability of information on ADP fellowship program websites and other material they would like to see available. Focus groups were recorded, with data transcribed and coded using NVivo 11 and Dedoose. A coding scheme was deductively developed based on the core research questions. Results: The majority of participants (N = 27) identified areas of dissatisfaction with the content currently available on ADP websites. The sample was highly representative of racial and ethnic minoritized trainees (n = 12) and genderqueer/non-binary participants (n = 3). Three major themes were identified and durable across all focus groups: lack of emphasis on diversity/health equity, lack of portrayal of everyday life and activities of fellows, and inadequate representation of curricula. Overwhelmingly, participants identified a dedication to health equity (for example, working with minoritized populations) as a key deciding factor in whether to apply to a particular ADP fellowship. Conclusions: ADP fellowship websites are perceived to have considerable variability in the amount and quality of information. Many do not appear to provide the full spectrum of content desired by diverse potential applicants, such as information regarding current fellows and community-centered initiatives. This is concerning, as it suggests ADP fellowships may be interfacing poorly with burgeoning leaders, especially those from race and gender minoritized backgrounds, neglecting potential opportunities to develop future addiction specialists.

背景:在美国,成瘾精神病学家的短缺令人担忧。为了促进对成瘾精神病学(ADP)的兴趣,必须通过ADP奖学金网站最大限度地利用资源。本研究的目的是调查ADP奖学金网站内容的充分性和可访问性,并发现有兴趣成为成瘾专家的受训者认为哪些进一步的信息是重要的。方法:于2021年1 - 2月在不同地理区域的医学生和住院医师中进行了三个虚拟焦点小组。参与者被问及ADP奖学金项目网站上的信息和他们希望看到的其他材料的可用性。对焦点组进行记录,使用NVivo 11和Dedoose对数据进行转录和编码。基于核心研究问题,推导出编码方案。结果:大多数参与者(N = 27)确定了对当前ADP网站上提供的内容不满意的领域。该样本在种族和少数民族学员(n = 12)和性别酷儿/非二元参与者(n = 3)中具有高度代表性。确定了三个主要主题,并在所有焦点小组中持久存在:缺乏对多样性/健康公平的强调,缺乏对研究员日常生活和活动的描述,以及课程代表性不足。绝大多数参与者认为,致力于健康公平(例如,与少数群体合作)是决定是否申请特定ADP奖学金的关键因素。结论:ADP奖学金网站被认为在信息的数量和质量上有相当大的可变性。许多机构似乎没有提供各种潜在申请者所需的全部内容,比如有关当前研究员和以社区为中心的倡议的信息。这一点令人担忧,因为它表明,ADP奖学金可能与新兴领导者(尤其是那些来自种族和性别少数背景的领导者)的联系不佳,忽视了培养未来成瘾专家的潜在机会。
{"title":"Perceptions on navigating ACGME-accredited addiction psychiatry fellowship program websites: A thematic analysis across a race- and gender-diverse pool of potential applicants.","authors":"Matthew P Abrams,&nbsp;Danielle S Jackson,&nbsp;Amaka Aneke-Gratia,&nbsp;Anne E Kohler,&nbsp;Nicky Mehtani,&nbsp;Ayana Jordan","doi":"10.1080/08897077.2022.2028703","DOIUrl":"https://doi.org/10.1080/08897077.2022.2028703","url":null,"abstract":"<p><p><i>Background:</i> There is an alarming shortage of addiction psychiatrists in the United States. To promote interest in addiction psychiatry (ADP), it is essential to maximize resources available through ADP fellowship websites. The aim of this study was to investigate the perceived adequacy and accessibility of content on ADP fellowship websites and discover what further information is considered important among trainees interested in becoming addiction specialists. <i>Methods:</i> Three virtual focus groups were conducted between January and February 2021 among medical students and residents in diverse geographic regions. Participants were asked about the availability of information on ADP fellowship program websites and other material they would like to see available. Focus groups were recorded, with data transcribed and coded using NVivo 11 and Dedoose. A coding scheme was deductively developed based on the core research questions. <i>Results:</i> The majority of participants (<i>N</i> = 27) identified areas of dissatisfaction with the content currently available on ADP websites. The sample was highly representative of racial and ethnic minoritized trainees (<i>n</i> = 12) and genderqueer/non-binary participants (<i>n</i> = 3). Three major themes were identified and durable across all focus groups: lack of emphasis on diversity/health equity, lack of portrayal of everyday life and activities of fellows, and inadequate representation of curricula. Overwhelmingly, participants identified a dedication to health equity (for example, working with minoritized populations) as a key deciding factor in whether to apply to a particular ADP fellowship. <i>Conclusions:</i> ADP fellowship websites are perceived to have considerable variability in the amount and quality of information. Many do not appear to provide the full spectrum of content desired by diverse potential applicants, such as information regarding current fellows and community-centered initiatives. This is concerning, as it suggests ADP fellowships may be interfacing poorly with burgeoning leaders, especially those from race and gender minoritized backgrounds, neglecting potential opportunities to develop future addiction specialists.</p>","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10713832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Perceptions of peer and parental attitudes toward substance use and actual adolescent substance use: The impact of adolescent-confidant relationships. 同伴和父母对物质使用和青少年实际物质使用的态度的认知:青少年-知己关系的影响。
IF 3.5 3区 医学 Q2 Medicine Pub Date : 2022-01-01 DOI: 10.1080/08897077.2022.2060439
Megan E Marziali, Natalie S Levy, Silvia S Martins

Objective: While peer influence is a well-documented risk factor for adolescent substance use, it remains unclear whether peer or parental attitudes have greater impact, and if this relationship is moderated by having a confidant and the relationship between adolescents and their confidant. Method: Pooled (2015-2018) National Survey on Drug Use and Health (NSDUH) data on adolescents (12-17 years) were used. Perceived peer and parental disapproval of tobacco, alcohol, and marijuana use were dichotomized. We assessed associations between disapproval and past-month tobacco (N = 51,352), alcohol (N = 51,407), and marijuana use (N = 51,355) using separate multivariable logistic regression models. We explored effect modification by the presence of a confidant, parental vs. non-parental disapproval, and peer vs. non-peer confidant relationship. Results: Peer and parental disapproval, presence of any confidant, and identifying a parental confidant were consistently protective against substance use; identifying a peer confidant increased odds of use across substances. For marijuana use, peer disapproval (adjusted odds ratio [aOR]: 0.07, 95% confidence interval [CI]: 0.06, 0.08) was more protective than parental disapproval (aOR: 0.13, 95% CI: 0.12, 0.15). The joint presence of peer/parental disapproval and any confidant decreased the odds of substance use beyond the individual effects of peer/parental disapproval and having a confidant. However, having a peer confidant attenuated the protective association between peer/parental disapproval and tobacco, alcohol, and marijuana use. Conclusions: Both peer and parental relationships are salient when considering the social context of adolescent substance use and should be considered when studying the effects of perceived disapproval.

目的:虽然同伴影响是青少年药物使用的一个充分记录的风险因素,但尚不清楚同伴或父母的态度是否有更大的影响,以及这种关系是否通过拥有知己以及青少年与其知己之间的关系来调节。方法:采用2015-2018年全国青少年药物使用与健康调查(NSDUH)汇总数据。感知同伴和父母对烟草、酒精和大麻使用的不赞成被分为两类。我们使用独立的多变量logistic回归模型评估了不赞成与过去一个月吸烟(N = 51,352)、饮酒(N = 51,407)和大麻使用(N = 51,355)之间的关系。我们探讨了知己的存在、父母与非父母的反对、同伴与非同伴的知己关系对效果的影响。结果:同伴和父母的反对,任何知己的存在,以及确定一个父母的知己对药物使用具有一致的保护作用;确定一个同辈知己增加了使用各种物质的几率。对于大麻使用,同伴不赞成(调整比值比[aOR]: 0.07, 95%可信区间[CI]: 0.06, 0.08)比父母不赞成(aOR: 0.13, 95% CI: 0.12, 0.15)更具保护作用。同伴/父母的反对和任何知己的共同存在降低了物质使用的几率,超出了同伴/父母的反对和有知己的个人影响。然而,有一个同伴知己会减弱同伴/父母的反对与吸烟、饮酒和吸食大麻之间的保护性联系。结论:在考虑青少年药物使用的社会背景时,同伴和父母关系都是显著的,在研究感知不赞成的影响时应考虑到这一点。
{"title":"Perceptions of peer and parental attitudes toward substance use and actual adolescent substance use: The impact of adolescent-confidant relationships.","authors":"Megan E Marziali,&nbsp;Natalie S Levy,&nbsp;Silvia S Martins","doi":"10.1080/08897077.2022.2060439","DOIUrl":"https://doi.org/10.1080/08897077.2022.2060439","url":null,"abstract":"<p><p><i>Objective:</i> While peer influence is a well-documented risk factor for adolescent substance use, it remains unclear whether peer or parental attitudes have greater impact, and if this relationship is moderated by having a confidant and the relationship between adolescents and their confidant. <i>Method</i>: Pooled (2015-2018) National Survey on Drug Use and Health (NSDUH) data on adolescents (12-17 years) were used. Perceived peer and parental disapproval of tobacco, alcohol, and marijuana use were dichotomized. We assessed associations between disapproval and past-month tobacco (<i>N</i> = 51,352), alcohol (<i>N</i> = 51,407), and marijuana use (<i>N</i> = 51,355) using separate multivariable logistic regression models. We explored effect modification by the presence of a confidant, parental vs. non-parental disapproval, and peer vs. non-peer confidant relationship. <i>Results</i>: Peer and parental disapproval, presence of any confidant, and identifying a parental confidant were consistently protective against substance use; identifying a peer confidant increased odds of use across substances. For marijuana use, peer disapproval (adjusted odds ratio [aOR]: 0.07, 95% confidence interval [CI]: 0.06, 0.08) was more protective than parental disapproval (aOR: 0.13, 95% CI: 0.12, 0.15). The joint presence of peer/parental disapproval and any confidant decreased the odds of substance use beyond the individual effects of peer/parental disapproval and having a confidant. However, having a peer confidant attenuated the protective association between peer/parental disapproval and tobacco, alcohol, and marijuana use. <i>Conclusions</i>: Both peer and parental relationships are salient when considering the social context of adolescent substance use and should be considered when studying the effects of perceived disapproval.</p>","PeriodicalId":22108,"journal":{"name":"Substance abuse","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706817/pdf/nihms-1850037.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10825805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Substance abuse
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1